Not applicableStudy completedNCT00681499What this trial is testingQuality of Life After Liver ResectionWho this might be right forLiver DiseasesLiver Neoplasms University of Bern 198
Testing effectiveness (Phase 2)Ended earlyNCT05220722What this trial is testingPressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver TumorsWho this might be right forHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma TriSalus Life Sciences, Inc. 23
Early research (Phase 1)Study completedNCT00118170What this trial is testingSorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney FunctionWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+42 more National Cancer Institute (NCI) 150
Early research (Phase 1)Study completedNCT00732836What this trial is testingHepatic Arterial Infusion (HAI) of AbraxaneWho this might be right forLiver CancerAdvanced CancersSolid Tumors M.D. Anderson Cancer Center 64
Large-scale testing (Phase 3)Study completedNCT00324727What this trial is testingHepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin)Metastatic Cancer Delcath Systems Inc. 93
Not applicableStudy completedNCT03867916What this trial is testingPatient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsWho this might be right forCaregiverMalignant NeoplasmPhysician+24 more University of California, San Francisco 106
Not applicableLooking for participantsNCT07364474What this trial is testingImmune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the LiverWho this might be right forUveal Melanoma Massachusetts General Hospital 10
Early research (Phase 1)Study completedNCT01140607What this trial is testingSafety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentWho this might be right forNeoplasm Malignant Sanofi 56
Testing effectiveness (Phase 2)Looking for participantsNCT07145801What this trial is testingY-90 Treatment Response Using Transarterial RadioembolizationWho this might be right forHCCHepatocellular CarcinomaLiver Cancer+3 more Thomas Jefferson University 30
Not applicableUnknownNCT03149523What this trial is testingExhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver TumorsWho this might be right forColorectal AdenocarcinomaHepatic CarcinomaKidney Adenocarcinoma European Georges Pompidou Hospital 150
Early research (Phase 1)Not Yet RecruitingNCT07183852What this trial is testingLocoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic MelanomaWho this might be right forMetastatic Uveal MelanomaMetastatic Cutaneous Melanoma Vastra Gotaland Region 18
Large-scale testing (Phase 3)Ended earlyNCT00110123What this trial is testingIntravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye MelanomaWho this might be right forIntraocular MelanomaMetastatic Cancer European Organisation for Research and Treatment of Cancer - EORTC 171
Early research (Phase 1)Study completedNCT00421044What this trial is testingPatupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionWho this might be right forAdvanced MalignanciesTumors Novartis Pharmaceuticals 14
Early research (Phase 1)WithdrawnNCT03217253What this trial is testingTazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver DysfunctionWho this might be right forAnn Arbor Stage III B-Cell Non-Hodgkin LymphomaAnn Arbor Stage IV B-Cell Non-Hodgkin LymphomaMetastatic Malignant Solid Neoplasm+8 more National Cancer Institute (NCI)
Large-scale testing (Phase 3)Looking for participantsNCT05863195What this trial is testingTesting Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialWho this might be right forMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverStage IV Colorectal Cancer AJCC v8+1 more ECOG-ACRIN Cancer Research Group 408
Early research (Phase 1)Study completedNCT05788484What this trial is testingCDX-585 in Patients With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerGastric CancerHead and Neck Cancer+11 more Celldex Therapeutics 20
Not applicableEnded earlyNCT02336763What this trial is testingRadiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver MetastasesWho this might be right forIris MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIA Uveal Melanoma+4 more Jonsson Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00187109What this trial is testingRecombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide ChemotherapyWho this might be right forGerm Cell TumorsHepatic CancerNeuroblastoma+2 more St. Jude Children's Research Hospital 40
Early research (Phase 1)Study completedNCT00145041What this trial is testingPharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic DysfunctionWho this might be right forMalignant Melanoma Acrotech Biopharma Inc. 7
Early research (Phase 1)Study completedNCT05169957What this trial is testingHepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)Who this might be right forMelanoma, OcularMelanoma, CutaneousMetastatic Melanoma+2 more University of Michigan Rogel Cancer Center 2